Table 2a.
BRAF mutation (%) | ||||
---|---|---|---|---|
CSD 0-3 | CSD 4-6 | CSD 7-10 | p-value* | |
European and North American melanomas | ||||
Face or scalp (n=74) | 100% 4 of 4 |
31% 4 of 13 |
18% 10 of 57 |
P=0.002 |
Upper extremities (n=51) | 64% 9 of 14 |
33% 7 of 21 |
13% 2 of 16 |
P=0.004 |
Trunk (n=200) | 68% 62 of 91 |
57% 56 of 99 |
50% 5 of 10 |
P=0.08 |
Lower extremities (n=99) | 61% 23 of 38 |
53% 28 of 53 |
50% 4 of 8 |
P=0.51 |
Australian melanomas | ||||
Face or scalp (n=62) | 0% 0 of 2 |
32% 6 of 19 |
24% 10 of 41 |
P=1.0 |
Trunk (n=58) | 88% 7 of 8 |
51% 19 of 37 |
39% 5 of 13 |
P=0.048 |
p-value of exact Chi-square test for trend.